Last 52 quarters of trend data · Healthcare · Cannabis
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.24 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.10 | 0.95 | 1.24 | 1.28 | 0.96 | 1.50 | 0.80 | 0.38 | 1.01 | 1.66 | 1.93 | 2.65 | 1.01 | 1.66 | 1.93 | 2.65 | 1.35 | 2.01 | 3.45 | 16.12 | 18.49 |
| — | -36.5% | +55.2% | +240.8% | -4.7% | -9.7% | -58.7% | -85.8% | 0.0% | 0.0% | 0.0% | 0.0% | -25.1% | -17.6% | -44.1% | -83.5% | -92.7% | -94.5% | -87.1% | -75.9% | -69.7% | |
| P/B Ratio | 3.93 | 0.41 | 0.58 | 0.52 | 0.38 | 0.54 | 0.47 | 0.20 | 0.51 | 0.82 | 0.96 | 1.54 | 0.51 | 0.82 | 0.96 | 1.54 | 0.78 | 0.75 | 1.65 | 6.25 | 5.91 |
| — | -24.9% | +24.0% | +160.8% | -25.9% | -33.8% | -51.0% | -87.0% | 0.0% | 0.0% | 0.0% | 0.0% | -34.3% | +9.7% | -41.8% | -75.3% | -86.8% | -93.0% | -81.0% | -24.2% | -42.8% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | 11.74 | — | — | — | — | — | — | — | — | — | 49.14 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | 12.25 | — | — | — | — | — | — | — | — | — | — | — | — | 15.95 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 24.5% | 23.5% | 27.4% | 11.6% | 28.8% | 32.8% | 25.0% | 16.2% | 32.2% | 34.7% | 34.8% | 21.3% | 32.2% | 34.7% | 34.8% | 21.3% | 36.0% | 33.7% | 18.0% | -141.3% | 6.2% |
| — | -28.6% | +9.6% | -28.5% | -10.7% | -5.2% | -28.1% | -23.7% | 0.0% | 0.0% | 0.0% | 0.0% | -10.3% | +3.0% | +92.7% | +115.0% | +483.5% | +4944.6% | +442.2% | +0.9% | -13.9% | |
| Operating Margin | -25.7% | -23.1% | -27.2% | -38.6% | -35.3% | -25.3% | -31.4% | -6.7% | -31.9% | -72.9% | -44.0% | -146.6% | -31.9% | -72.9% | -44.0% | -146.6% | -76.8% | -10.1% | -71.7% | -923.1% | -132.8% |
| — | +8.9% | +13.1% | -471.4% | -10.9% | +65.3% | +28.7% | +95.4% | 0.0% | 0.0% | 0.0% | 0.0% | +58.5% | -624.4% | +38.7% | +84.1% | +42.2% | +94.1% | +95.9% | -94.8% | -24.8% | |
| Net Margin | -92.4% | -56.7% | -18.0% | -220.5% | -84.0% | -2.5% | -57.6% | -339.5% | -163.0% | -203.7% | -192.0% | -126.9% | -163.0% | -203.7% | -192.0% | -126.9% | -276.2% | -445.5% | -50.0% | -965.4% | -305.8% |
| — | -2207.2% | +68.8% | +35.0% | +48.5% | +98.8% | +70.0% | -167.6% | 0.0% | 0.0% | 0.0% | 0.0% | +41.0% | +54.3% | -284.1% | +86.9% | +9.7% | -34.1% | +97.5% | -87.8% | -295.8% |
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -44.4% | -7.0% | -2.1% | -18.1% | -9.7% | -0.3% | -8.5% | -40.9% | -22.1% | -24.6% | -24.6% | -17.7% | -22.1% | -24.6% | -24.6% | -17.7% | -33.5% | -44.6% | -5.4% | -78.1% | -22.9% |
| — | -2506.8% | +75.3% | +55.8% | +56.3% | +98.9% | +65.4% | -131.7% | 0.0% | 0.0% | 0.0% | 0.0% | +33.9% | +44.9% | -351.6% | +77.4% | -46.2% | -91.7% | +93.6% | -372.4% | -608.0% | |
| ROA | -25.8% | -4.3% | -1.3% | -11.9% | -6.6% | -0.2% | -4.6% | -21.2% | -10.2% | -10.2% | -9.8% | -6.9% | -10.2% | -10.2% | -9.8% | -6.9% | -14.3% | -18.7% | -1.9% | -30.5% | -11.1% |
| — | -2499.5% | +71.2% | +43.8% | +34.7% | +98.4% | +53.6% | -205.5% | 0.0% | 0.0% | 0.0% | 0.0% | +29.0% | +45.4% | -427.7% | +77.2% | -29.3% | -65.8% | +96.3% | -181.1% | -413.6% | |
| ROIC | -8.2% | -2.2% | -2.7% | -2.8% | -3.4% | -1.8% | -2.4% | -0.4% | -2.0% | -3.7% | -2.2% | -7.6% | -2.0% | -3.7% | -2.2% | -7.6% | -3.8% | -0.4% | -3.2% | -32.9% | -5.1% |
| — | -21.2% | -11.2% | -588.2% | -74.5% | +50.7% | -8.0% | +94.8% | 0.0% | 0.0% | 0.0% | 0.0% | +48.4% | -735.1% | +29.5% | +76.7% | +24.7% | +92.7% | +92.6% | -257.4% | -85.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.40 | 0.38 | 0.40 | 0.40 | 0.34 | 0.35 | 0.67 | 0.72 | 0.83 | 1.20 | 1.17 | 1.33 | 0.83 | 1.20 | 1.17 | 1.33 | 1.27 | 1.02 | 1.34 | 1.86 | 0.92 |
| — | +7.3% | -39.9% | -44.1% | -59.4% | -70.7% | -42.7% | -46.4% | 0.0% | 0.0% | 0.0% | 0.0% | -35.0% | +17.9% | -12.6% | -28.2% | +38.4% | +14.6% | +39.1% | +310.6% | +134.3% | |
| Debt / EBITDA | — | — | — | — | — | — | — | 49.22 | — | — | — | — | — | — | — | — | — | 138.54 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.34 | 2.82 | 3.04 | 3.34 | 5.34 | 5.50 | 3.07 | 3.12 | 3.52 | 1.39 | 2.15 | 1.58 | 3.52 | 1.39 | 2.15 | 1.58 | 1.79 | 2.52 | 1.96 | 1.34 | 1.73 |
| — | -48.7% | -1.2% | +7.1% | +51.8% | +294.8% | +43.2% | +97.3% | 0.0% | 0.0% | 0.0% | 0.0% | +95.9% | -44.6% | +9.7% | +18.0% | +3.9% | -11.3% | -50.3% | -83.5% | -79.2% | |
| Quick Ratio | 2.37 | 2.20 | 2.39 | 2.64 | 4.26 | 4.23 | 2.12 | 2.10 | 2.58 | 1.07 | 1.64 | 1.25 | 2.58 | 1.07 | 1.64 | 1.25 | 1.40 | 2.07 | 1.64 | 1.24 | 1.41 |
| — | -48.0% | +12.6% | +25.9% | +65.2% | +295.0% | +29.5% | +67.7% | 0.0% | 0.0% | 0.0% | 0.0% | +84.5% | -48.1% | -0.2% | +1.3% | -1.0% | -15.5% | -52.1% | -82.7% | -79.2% | |
| Interest Coverage | -5.88 | — | -1.16 | -11.83 | -7.48 | 0.84 | -3.23 | -13.38 | -6.25 | -5.17 | -4.82 | -3.55 | -6.25 | -5.17 | -4.82 | -3.55 | -8.40 | -3.94 | 0.73 | -19.84 | -5.86 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 52 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CGC stock.
Canopy Growth Corporation's current P/E is -1.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Canopy Growth Corporation's current operating margin is -25.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Canopy Growth Corporation's business trajectory between earnings reports.